How have INO and LUNG total returns compared?

Over the past 5 years, INO delivered -57.05% and LUNG delivered -45.30% annualized total return. Past performance doesn't predict future results.

Inovio Pharmaceuticals, Inc. (INO) vs Pulmonx Corporation (LUNG)

A side-by-side comparison of Inovio Pharmaceuticals, Inc. and Pulmonx Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

INO

Inovio Pharmaceuticals, Inc.

$79M

$1.14HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT

LUNG

Pulmonx Corporation

$80M

$1.90HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT

Total return — INO vs LUNG

growth of $100 · dividends reinvested · last 6y

INO -99.2% (-55.0%/yr)LUNG -95.2% (-39.8%/yr)LUNG compounded faster over this window

Log scale — wide-divergence pair

INO LUNG

INO vs LUNG: by the numbers

•LUNG is the larger company ($80M vs $79M market cap).
•Both run net losses; LUNG's is the smaller (-55.03% vs -130000.00% net margin).

Metrics side by side

Valuation

Metric	INO	LUNG
P/S ratio	N/A	0.92
P/B ratio	18.02	2.04

Profitability

Metric	INO	LUNG
Gross margin	100.00%	77.06%
Operating margin	-132871.32%	-52.96%
Net margin	-130000.00%	-55.03%
ROE	-1542.57%	-122.76%
ROIC	-836.58%	-48.39%

Growth (annualized)

Metric	INO	LUNG
Revenue CAGR (5Y)	N/A	15.86%
Total return CAGR (5Y)	-57.05%	-45.30%

Frequently asked

How have INO and LUNG total returns compared?: Over the past 5 years, INO delivered -57.05% and LUNG delivered -45.30% annualized total return. Past performance doesn't predict future results.

Go deeper

Full INO analysis Full LUNG analysis Interactive comparison tool

Dig into the metrics

Inovio Pharmaceuticals ROE Pulmonx ROE Inovio Pharmaceuticals operating margin Pulmonx operating margin Inovio Pharmaceuticals revenue growth Pulmonx revenue growth Inovio Pharmaceuticals free cash flow Pulmonx free cash flow

Inovio Pharmaceuticals & Pulmonx appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.